Product Introduction
Bioactivity


英文名: Siltuximab

描述: Siltuximab（CNTO-328） 是一种靶向 IL-6 且具有抗肿瘤活性的单克隆抗体，可用于研究巨大淋巴结增生症 (MCD) 和 COVID-19。

体内活性: In xenograft mouse models, Siltuximab, when administered through intraperitoneal injection at a dosage of 10 mg/kg three times per week, inhibits the growth of lung cancer cells[1]. Furthermore, in a xenograft model, the growth of MCF-7 tumors is inhibited by Siltuximab with intraperitoneal injections at a dose of 20 mg/kg twice per week for 6 weeks[3].

存储条件: store at low temperaturestore at -80°C

相关产品: Platycodin D2 | N-Decyl-4-methoxyaniline | GSK717 | Myristicin | Carpinontriol B | Neoisoastilbin | 6,4'-Dihydroxy-7-methoxyflavanone | SDZ 224-015 | BIRT-377 | Ilexgenin A